v3.26.3
Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Non-redeemable
Share Subscription Receivable from Stockholder
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Nov. 30, 2024 $ 575 $ (25,000) $ 24,425 $ (1,275) $ (1,275)
Balance (in Shares) at Nov. 30, 2024 [1],[2] 5,750,000        
Collection of share subscription receivable 25,000 25,000
Net income (loss) (72,670) (72,670)
Balance at Feb. 28, 2025 $ 575 24,425 (73,945) (48,945)
Balance (in Shares) at Feb. 28, 2025 [1],[2] 5,750,000        
Balance at Nov. 30, 2024 $ 575 (25,000) 24,425 (1,275) (1,275)
Balance (in Shares) at Nov. 30, 2024 [1],[2] 5,750,000        
Net income (loss)         (167,328)
Balance at Aug. 31, 2025 $ 575 24,425 (168,603) (143,603)
Balance (in Shares) at Aug. 31, 2025 [1],[2] 5,750,000        
Balance at Feb. 28, 2025 $ 575 24,425 (73,945) (48,945)
Balance (in Shares) at Feb. 28, 2025 [1],[2] 5,750,000        
Net income (loss) (23,187) (23,187)
Balance at May. 31, 2025 $ 575 24,425 (97,132) (72,132)
Balance (in Shares) at May. 31, 2025 [1],[2] 5,750,000        
Net income (loss) (71,471) (71,471)
Balance at Aug. 31, 2025 $ 575 24,425 (168,603) (143,603)
Balance (in Shares) at Aug. 31, 2025 [1],[2] 5,750,000        
Balance at Nov. 30, 2025 $ 575   31,425 (205,666) (173,666)
Balance (in Shares) at Nov. 30, 2025 [1],[2] 5,750,000        
Sale of 570,000 Private Placement Units $ 57   5,699,943 5,700,000
Sale of 570,000 Private Placement Units (in Shares) [1],[2] 570,000        
Fair value of rights included in Public Shares   3,404,000 3,404,000
Allocated value of transaction costs to Public Rights and Private Placement Units   (245,984) (245,984)
Accretion for ordinary shares, subject to possible redemption to redemption value   (8,889,384) (11,320,588) (20,209,972)
Net income (loss)   1,358,897 1,358,897
Balance at Feb. 28, 2026 $ 632   (10,167,357) (10,166,725)
Balance (in Shares) at Feb. 28, 2026 [1],[2] 6,320,000        
Balance at Nov. 30, 2025 $ 575   31,425 (205,666) (173,666)
Balance (in Shares) at Nov. 30, 2025 [1],[2] 5,750,000        
Net income (loss)         4,535,965
Balance at Aug. 31, 2026 $ 632   (11,174,248) (11,173,616)
Balance (in Shares) at Aug. 31, 2026 [1],[2] 6,320,000        
Balance at Feb. 28, 2026 $ 632   (10,167,357) (10,166,725)
Balance (in Shares) at Feb. 28, 2026 [1],[2] 6,320,000        
Accretion for ordinary shares, subject to possible redemption to redemption value   (2,074,592) (2,074,592)
Net income (loss)   1,301,099 1,301,099
Balance at May. 31, 2026 $ 632   (10,940,850) (10,940,218)
Balance (in Shares) at May. 31, 2026 [1],[2] 6,320,000        
Accretion for ordinary shares, subject to possible redemption to redemption value   (2,109,367) (2,109,367)
Net income (loss)   1,875,969 1,875,969
Balance at Aug. 31, 2026 $ 632   $ (11,174,248) $ (11,173,616)
Balance (in Shares) at Aug. 31, 2026 [1],[2] 6,320,000        
[1] All share and per-share data have been retrospectively presented to reflect the 5,750,000 Founder Shares held by the Sponsor. See Notes 1 and 6.
[2] Includes up to 750,000 ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On December 18, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 ordinary shares are no longer subject to forfeiture (Note 6).